Initial Clinical Outcomes in the Treatment of Brain Metastasis With Gyroscopic Radiosurgery at a Single Institution

Tamra-Lee McCleary; Neelan J Marianayagam; Lorenzo Yuan; Kelly H Yoo; Vashisht Sekar; Amit Persad; David J Park; Antonio Meola; Peter D Klassen; Steven D. Chang

doi:10.7759/cureus.97282

journal article Nov 19, 2025

Initial Clinical Outcomes in the Treatment of Brain Metastasis With Gyroscopic Radiosurgery at a Single Institution

Tamra-Lee McCleary Neelan J Marianayagam Lorenzo Yuan Kelly H Yoo Vashisht Sekar Amit Persad David J Park Antonio Meola Peter D Klassen Steven D. Chang

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.97282

Topics

No keywords indexed for this article. Browse by subject →

References

19

[1]

Giantini-Larsen AM, Juthani RG, Pannullo SC, Knisely JP. Novel approaches to the management of patients with 5-15 brain metastases: a narrative review. Chin Clin Oncol. 2022, 11:17. 10.21037/cco-22-15 10.21037/cco-22-15

[2]

Hughes RT, McTyre ER, LeCompte M, et al.. Clinical outcomes of upfront stereotactic radiosurgery alone for patients with 5 to 15 brain metastases. Neurosurgery. 2019, 85:257-63. 10.1093/neuros/nyy276 10.1093/neuros/nyy276

[3]

Brown PD, Jaeckle K, Ballman KV, et al.. Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016, 316:401-9. 10.1001/jama.2016.9839 10.1001/jama.2016.9839

[4]

De Salles AA, Gorgulho AA, Pereira JL, McLaughlin N. Intracranial stereotactic radiosurgery: concepts and techniques. Neurosurg Clin N Am. 2013, 24:491-8. 10.1016/j.nec.2013.07.001 10.1016/j.nec.2013.07.001

[5]

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E.A. Eisenhauer, P. Therasse, J. Bogaerts et al.

European Journal of Cancer 2009 10.1016/j.ejca.2008.10.026

[6]

Wen PY, Macdonald DR, Reardon DA, et al.. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol. 2010, 28:1963-72. 10.1200/JCO.2009.26.3541 10.1200/jco.2009.26.3541

[7]

Weidlich GA, Schneider MB, Adler JR. Characterization of a novel revolving radiation collimator. Cureus. 2018, 10:e2146. 10.7759/cureus.2146 10.7759/cureus.2146

[8]

Weidlich GA, Schneider MB, Adler JR. Self-shielding analysis of the Zap-X system. Cureus. 2017, 9:e1917. 10.7759/cureus.1917 10.7759/cureus.1917

[9]

Myall NJ, Yu H, Soltys SG, Wakelee HA, Pollom E. Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies. Neurooncol Adv. 2021, 3:v52-62. 10.1093/noajnl/vdab106 10.1093/noajnl/vdab106

[10]

Weidlich GA, Bodduluri M, Achkire Y, Lee C, Adler JR Jr. Characterization of a novel 3 megavolt linear accelerator for dedicated intracranial stereotactic radiosurgery. Cureus. 2019, 11:e4275. 10.7759/cureus.4275 10.7759/cureus.4275

[11]

Muacevic A, Eder MM, Hofmann T, Fürweger C, Ehret F. Self-shielding gyroscopic radiosurgery-a first clinical experience, case series, and dosimetric comparison. World Neurosurg. 2022, 164:e420-6. 10.1016/j.wneu.2022.04.120 10.1016/j.wneu.2022.04.120

[12]

Klassen PD, Ivaturi SK, Hendricks BK. Trigeminal rhizotomy using gyroscopic radiosurgery: a case report. Cureus. 2022, 14:e24951. 10.7759/cureus.24951 10.7759/cureus.24951

[13]

Pan L, Qu B, Bai J, et al.. The Zap-X radiosurgical system in the treatment of intracranial tumors: a technical case report. Neurosurgery. 2021, 88:E351-5. 10.1093/neuros/nyaa550 10.1093/neuros/nyaa550

[14]

Hendricks BK, DiDomenico JD, Barani IJ, Barranco FD. ZAP-X gyroscopic radiosurgery system: a preliminary analysis of clinical applications within a retrospective case series. Stereotact Funct Neurosurg. 2022, 100:99-107. 10.1159/000519862 10.1159/000519862

[15]

Conti A, Tuleasca C. Letter: The Zap-X radiosurgical system in the treatment of intracranial tumors: a technical case report. Neurosurgery. 2021, 88:E577-8. 10.1093/neuros/nyab080 10.1093/neuros/nyab080

[16]

Chin AL, Li G, Gephart MH, Sandhu N, Nagpal S, Soltys SG, Pollom EL. Stereotactic radiosurgery after resection of brain metastases: changing patterns of care in the United States. World Neurosurg. 2020, 144:e797-806. 10.1016/j.wneu.2020.09.085 10.1016/j.wneu.2020.09.085

[17]

Ehret F, Kohlhase N, Eftimova D, et al.. Self-shielding gyroscopic radiosurgery: a prospective experience and analysis of the first 100 patients. Cureus. 2024, 16:e56035. 10.7759/cureus.56035 10.7759/cureus.56035

[18]

Gyroscopic Stereotactic Radiosurgery: A Retrospective Analysis

Dylan R Conroy, Susan M Woody, Ying E Niu et al.

Cureus 2025 10.7759/cureus.88553

[19]

Redmond KJ, Gui C, Benedict S, et al.. Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2021, 110:53-67. 10.1016/j.ijrobp.2020.10.034 10.1016/j.ijrobp.2020.10.034

Metrics

0

Citations

19

References

Details

Published: Nov 19, 2025

Authors

T

Tamra-Lee McCleary

N

Neelan J Marianayagam

Cite This Article

Tamra-Lee McCleary, Neelan J Marianayagam, Lorenzo Yuan, et al. (2025). Initial Clinical Outcomes in the Treatment of Brain Metastasis With Gyroscopic Radiosurgery at a Single Institution. Cureus. https://doi.org/10.7759/cureus.97282

Initial Clinical Outcomes in the Treatment of Brain Metastasis With Gyroscopic Radiosurgery at a Single Institution

You May Also Like